Clinical Trials Browser

Phase 2/3 × Active not recruiting × Dermatologic × Clear all

NCT02339571 2026-03-19

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

Phase 2/3 Active not recruiting

Melanoma

NCT06295809 2025-12-09

INTerpath-007

Phase 2/3 Active not recruiting

Carcinoma, Squamous Cell, Skin Neoplasms

NCT03470922 2025-09-09

RELATIVITY-047

Phase 2/3 Active not recruiting

714 enrolled 17 charts 1 FDA

Melanoma, Neoplasms